Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

Tizita Zeleke, Qingfei Pan, Codruța Chiuzan, Maika Onishi, Yuxin Li, Haiyan Tan, Mariano J. Alvarez, Erin Honan, Min Yang, Pei Ling Chia,

Nature Cancer · 2022 · 77 citations · 56 references

DOIFull text

Open access

Concepts

References

56